#2154565
PACLABÚTRASÓL
PACLOBUTRAZOL
Scag na torthaí
Bailiúcháin
23 toradh in 12 doiciméad
#2183837
Paclabútrasól (ISO) (CAS RN 76738-62-0)
Paclobutrazol (ISO) (CAS RN 76738-62-0)
#2607865
Paclabútrasól (ISO) (CAS RN 76738-62-0)
Paclobutrazol (ISO) (CAS RN 76738-62-0)
#2960860
(1) in Iarscríbhinn II, cuirtear an méid seo a leanas in ionad na gcolún le haghaidh iosocsaibeine, meataildéid agus paclabútrasóil:
(1) in Annex II, the columns for isoxaben, metaldehyde and paclobutrazol are replaced by the following:
#2960959
Paclabútrasól (suim d’isiméirí)
Paclobutrazol (sum of constituent isomers)
#2961274
Reasoned Opinion on the evaluation of confirmatory data following the Article 12 MRL review for paclobutrazol [Tuairim Réasúnaithe maidir leis an meastóireacht ar shonraí deimhniúcháin tar éis athbhreithniú Airteagal 12 ar MRLanna le haghaidh paclabútrasóil].
Reasoned Opinion on the evaluation of confirmatory data following the Article 12 MRL review for paclobutrazol.
#3145901
Paclabútrasól (ISO) (CAS RN 76738-62-0)
Paclobutrazol (ISO) (CAS RN 76738-62-0)
#2147359
Paclabútrasól (ISO); (2RS,3RS)-1-(4-clóraifeinil)-4,4-démheitil-2-(1H-1,2,4-tríasól-1-il)peantán-3-ól
Paclobutrazol (ISO); (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl- 2-(1H-1,2,4-triazol-1- yl)pentan-3-ol
#2770906
Le Rialachán Cur Chun Feidhme (AE) 2018/1266 ón gCoimisiún cuirtear síneadh le tréimhse formheasa na substaintí gníomhacha cleataidim, cioglocsaidim, dasaimeit, déchlófop, feanasacuin, himeacsasól, aigéad iondóiliolbútarach, meataildéad, agus paclabútrasól go dtí an 31 Bealtaine 2023.
Commission Implementing Regulation (EU) 2018/1266 extends the approval period of the active substances clethodim, cycloxydim, dazomet, diclofop, fenazaquin, hymexazol, indolylbutyric acid, metaldehyde and paclobutrazol until 31 May 2023.
#2770991
sa séú colún, dul in éag an fhormheasa, de ró 348, Paclabútrasól, cuirtear “31 Lúnasa 2026” in ionad an dáta;
in the sixth column, expiration of approval, of row 348, Paclobutrazol, the date is replaced by ‘31 August 2026’;
#2960816
(1) I gcás iosocsaibeine, meataildéid agus paclabútrasóil, leagadh síos uasleibhéil iarmhar (‘MRLanna’) in Iarscríbhinn II a ghabhann le Rialachán (CE) Uimh. 396/2005.
(1) For isoxaben, metaldehyde and paclobutrazol, maximum residue levels (‘MRLs’) were set in Annex II to Regulation (EC) No 396/2005.
#2043262
Rialachán Cur Chun Feidhme (AE) 2018/1266 ón gCoimisiún an 20 Meán Fómhair 2018 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 maidir le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 1-deacánól, 6-beinsioladainín, sulfáit alúmanaim, asadaraictin, búipireamáit, carbocsain, cleataidim, cioglocsaidim, dasaimeit, déchlófop, déthianón, dóidín, feanasacuin, fluometuron, flutríafól, heicsitiasocs, himeacsasól, aigéad iondoiliolbútarach, iosocsaibein, sulfar aoil, meataildéad, paclabútrasól, peinciocúrón, sintifein, tó-fluvailionáit agus teabúifeanóisíd (IO L 238, 21.9.2018, lch. 81).
Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide (OJ L 238, 21.9.2018, p. 81).
#2383798
Rialachán Cur Chun Feidhme (AE) 2018/1266 ón gCoimisiún an 20 Meán Fómhair 2018 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 1-deacánól, 6-beinsioladainín, sulfáit alúmanaim, asadaraictin, búipireamáit, carbocsain, cleataidim, cioglocsaidim, dasaimeit, déchlófop, déthianón, dóidín, feanasacuin, fluometuron, flutríafól, heicsitiasocs, himeacsasól, aigéad iondoiliolbútarach, iosocsaibein, sulfar aoil, meataildéad, paclabútrasól, peinciocúrón, sintifein, tó-fluvailionáit agus teabúifeanóisíd, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide is to be incorporated into the EEA Agreement.
#2654280
Rialachán (AE) 2019/89 ón gCoimisiún an 18 Eanáir 2019 lena leasaítear Iarscríbhinn II, III agus V a ghabhann le Rialachán (CE) 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil d’iarmhair maidir le brómaidé-ólón, eatafeanprocs, paclabútrasól agus peanconasól i dtáirgí áirithe, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2019/89 of 18 January 2019 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bromadiolone, etofenprox, paclobutrazol and penconazole in or on certain products is to be incorporated into the EEA Agreement.
#2770898
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, aigéad iondóiliolbútarach, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, feinmeideafam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237
#2770918
Maidir leis na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, feanasacuin, fluaipicilíd, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, paclabútrasól, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237, níl an measúnú riosca a rinne na Ballstáit is rapóirtéirí lena mbaineann de bhun Airteagal 11 de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012 tugtha chun críche go fóill.
For the active substances aclonifen, ametoctradin, beflubutamid, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, fenazaquin, fluopicolide, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, paclobutrazol, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 has not yet been finalised by the respective rapporteur Member States.
#2770931
Ós rud é go rachaidh an formheas reatha maidir le cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, feanasacuin, fluaipicilíd, fluraclóradón, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, aigéad iondóiliolbútarach, meataildéad, paclabútrasól, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237 in éag an 31 Bealtaine 2023, ba cheart an Rialachán seo a theacht i bhfeidhm a luaithe is féidir.
Taking into account that the current approval of clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, fenazaquin, fluopicolide, flurochloridone, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, metaldehyde, paclobutrazol, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 expires on 31 May 2023, this Regulation should enter into force as soon as possible.
#2770946
Rialachán Cur Chun Feidhme (AE) 2018/1266 ón gCoimisiún an 20 Meán Fómhair 2018 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 1-deacánól, 6-beinsioladainín, sulfáit alúmanaim, asadaraictin, búipireamáit, carbocsain, cleataidim, cioglocsaidim, dasaimeit, déchlófop, déthianón, dóidín, feanasacuin, fluaimeatúrón, flutríafól, heicsitiasocs, himeacsasól, aigéad iondoiliolbútarach, iosocsaibein, sulfar aoil, meataildéad, paclabútrasól, peinciocúrón, sintifein, tó-fluvailionáit agus teabúifeanóisíd (IO L 238, 21.9.2018, lch. 81).
Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide (OJ L 238, 21.9.2018, p. 81).
#2771005
Maidir leis na substaintí gníomhacha démheatomorf, fluocsastróibin, foilpéad, foirmeiteanáit, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, feinmeideafam, pirimeafos-meitil agus própamacarb, d’iarr an tÚdarás faisnéis bhreise de bhun Airteagal 13(3a) de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012 chun measúnú a dhéanamh ar na critéir formheasa a leagtar amach i bpointe 3.6.5 agus i bpointe 3.8.2 d’Iarscríbhinn II a ghabhann le Rialachán (CE) Uimh. 1107/2009 agus chuir na hiarratasóirí isteach í laistigh den spriocdháta a leagadh síos.
For the active substances dimethomorph, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl and propamocarb, additional information for the purposes of assessment of the approval criteria set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, was requested by the Authority pursuant to Article 13(3a) of Implementing Regulation (EU) No 844/2012 and was submitted by the applicants within the deadline given.
#2960810
lena leasaítear Iarscríbhinní II agus IV a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar le haghaidh iosocsaibeine, meataildéid, Metarhizium brunneum tréithchineál Ma 43, paclabútrasóil agus Fearamóin Léipidipteire Slabhra Dhírigh i dtáirgí áirithe nó ar tháirgí áirithe
amending Annexes II and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for isoxaben, metaldehyde, Metarhizium brunneum strain Ma 43, paclobutrazol and Straight Chain Lepidopteran Pheromones (SCLP) in or on certain products
#2960821
(4) A mhéid a bhaineann le paclabútrasóil, chuir iarratasóir faisnéis isteach nach raibh ar fáil le linn an athbhreithnithe a rinneadh i gcomhréir le hAirteagal 12 de Rialachán (CE) Uimh. 396/2005 maidir le staidéar ionadaíoch inar imscrúdaíodh meitibileacht phríomhúil bharr i mbarra torthaí.
(4) As regards paclobutrazol, an applicant submitted information previously unavailable during the review conducted in accordance with Article 12 of Regulation (EC) No 396/2005 on a representative study investigating primary crop metabolism in fruit crops.
#3037471
Rialachán Cur Chun Feidhme (AE) 2023/918 ón gCoimisiún an 4 Bealtaine 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, aigéad iondóiliolbútarach, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, feinmeideafam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237 (IO L 119, 5.5.2023, lch. 160).
Commission Implementing Regulation (EU) 2023/918 of 4 May 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 (OJ L 119, 5.5.2023, p. 160).
#3043309
Rialachán Cur Chun Feidhme (AE) 2023/918 ón gCoimisiún an 4 Bealtaine 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aigéad iondóiliolbútarach, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, feinmeideafam, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, himeacsasól, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, Trichoderma asperellum tréithchineál T34, Trichoderma atroviride tréithchineál I-1237, víreas polaihéadróise núicléach Helicoverpa armigera agus víreas polaihéadróise núicléach Spodoptera littoralis, (IO L 119, 5.5.2023, lch. 160).
Commission Implementing Regulation (EU) 2023/918 of 4 May 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 (OJ L 119, 5.5.2023, p. 160).